AFC-HD AMS Life Science Co., Ltd. stock analysis
Want to see JP:2927 full AI Analyst Report?
AFC-HD AMS Life Science Co., Ltd. (2927) Stock Price & Analysis
2927 Stock Chart & Stats
- Day’s Range
- JPY 841.00 - JPY 854.00
- 52-Week Range
- JPY 810.00 - JPY 918.00
- Previous Close
- JPY 846.00
- Volume
- N/A
- Average Volume (3M)
- 21.04K
- Market Cap
- JPY 11.99B
- Enterprise Value
- JPY 26.59B
- Total Cash (Recent Filing)
- JPY 9.76B
- Total Debt (Recent Filing)
- JPY 23.41B
- Price to Earnings (P/E)
- 10.2
- Beta
- 0.30
- Next Earnings
- Jan 08, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Feb 25, 2027
- Dividend Yield
- 4.73%
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth
Consistent multi-year revenue expansion indicates sustained demand for the company’s health-related products and commercial offerings. Continued top-line growth can support operating scale, fund product development, and reinforce the company’s market position over the next several quarters.
Positive Operating Profitability
Positive operating profitability shows that the core business remains economically viable despite recent pressure on earnings. A moderate operating margin provides an earnings base that can support reinvestment and potentially benefit from stronger product mix, revenue scale, or cost discipline.
Improving Equity Base
Growing equity and a modest reduction in debt-to-equity improve balance-sheet resilience relative to prior years. Although leverage remains meaningful, the stronger capital base gives the company a better foundation to absorb operating volatility and pursue its health-products business.
Bears Say
Weak Free Cash Flow
Persistent negative free cash flow means reported earnings have not consistently converted into cash after investment needs. This can restrict internally funded growth, reduce capital-allocation flexibility, and make the company more dependent on balance-sheet resources while debt remains substantial.
Meaningful Leverage
Meaningful leverage increases the financial burden on a business whose profitability and cash generation have weakened. High debt relative to equity can constrain investment choices, increase sensitivity to operating setbacks, and slow the pace at which internally generated cash can strengthen the balance sheet.
Margin And Earnings Pressure
The decline in net margin and negative EPS growth indicate that earnings are weakening even as revenue expands. Lower profitability reduces the company’s ability to convert sales growth into durable shareholder returns and leaves less cushion against higher costs, weaker mix, or other operating pressures.
AFC-HD AMS Life Science Co., Ltd. News
2927 FAQ
What was AFC-HD AMS Life Science Co., Ltd.’s price range in the past 12 months?
What is AFC-HD AMS Life Science Co., Ltd.’s market cap?
When is AFC-HD AMS Life Science Co., Ltd.’s upcoming earnings report date?
How were AFC-HD AMS Life Science Co., Ltd.’s earnings last quarter?
Is AFC-HD AMS Life Science Co., Ltd. overvalued?
Does AFC-HD AMS Life Science Co., Ltd. pay dividends?
What is AFC-HD AMS Life Science Co., Ltd.’s EPS estimate?
How many shares outstanding does AFC-HD AMS Life Science Co., Ltd. have?
What happened to AFC-HD AMS Life Science Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AFC-HD AMS Life Science Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AFC-HD AMS Life Science Co., Ltd.
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Tsunenori Nishikiori
- Employees
- 1,008
- Website
- www.ams-life.com
- Address
- 3-6-36 Toyoda, Shizuoka, SZ, 422-8027, JP
AFC-HD AMS Life Science Co., Ltd. (2927) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 8 |
